City

Nashville (1)

New Taipei City (1)

Seoul (1)

Overall Status

Completed (1)

Recruiting (1)

Unknown status (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Korea University Anam Hospital (1)

Taipei Medical University Shuang Ho Hospital (1)

Vanderbilt University Medical Center (1)

Collaborator

Korean Breast Cancer Study Group (1)

National Cancer Center, Korea (1)

Intervention

tamoxifen (2)

placebo oral tablet (1)

tamoxifen 40 mg daily for one year (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (3)

Study Type

Interventional (2)

Observational (1)

tamoxifen

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hypertension, Pulmonary Arterial Hypertension, Familial Primary Pulmonary Hypertension Trial in Nashville (Tamoxifen, Placebo

Recruiting

Hypertension
+8 more

Tamoxifen
Placebo Oral Tablet

Nashville, Tennessee

Vanderbilt University Medical Center

Aug 22, 2022

Amyotrophic Lateral Sclerosis, ALS Functional Ration Scale, TAR-DNA-binding Protein-43 Trial in New Taipei City (tamoxifen 40 mg

Completed

Amyotrophic Lateral Sclerosis
+4 more

tamoxifen 40 mg daily for one year

New Taipei City, Taiwan

Po-Chih Chen

Sep 17, 2019

CYP2D6 Genotype on the Clinical Effect of Tamoxifen

Unknown status

Breast Neoplasms
+3 more

Tamoxifen

Seoul, Korea, Republic of

Korea University Anam Hopital

Sep 8, 2009